Annual Debt To Equity
N/A
31 December 2023
Summary:
AcelRx Pharmaceuticals annual debt to equity ratio is not available.ACRX Debt To Equity Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Debt To Equity
N/A
31 December 2023
Summary:
AcelRx Pharmaceuticals quarterly debt to equity ratio is not available.ACRX Quarterly Debt To Equity Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
ACRX Debt To Equity Performance
PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
---|---|---|
1 y1 year | - | - |
3 y3 years | - | - |
5 y5 years | - | - |
ACRX Debt To Equity High & Low
PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
---|---|---|---|---|---|
3 y | 3 years | ||||
5 y | 5 years | ||||
alltime | all time |
AcelRx Pharmaceuticals Debt To Equity History
Date | Annual | Quarterly |
---|---|---|
Sept 2023 | - | 0.00(0.0%) |
June 2023 | - | 0.00(-100.0%) |
Mar 2023 | - | 0.23(-11.5%) |
Dec 2022 | 0.26(-168.4%) | 0.26(-10.3%) |
Sept 2022 | - | 0.29(-3.3%) |
June 2022 | - | 0.30(-196.8%) |
Mar 2022 | - | -0.31(-18.4%) |
Dec 2021 | -0.38(-2.6%) | -0.38(+2.7%) |
Sept 2021 | - | -0.37(-26.0%) |
June 2021 | - | -0.50(-31.5%) |
Mar 2021 | - | -0.73(+87.2%) |
Dec 2020 | -0.39(-36.1%) | -0.39(-4.9%) |
Sept 2020 | - | -0.41(-4.7%) |
June 2020 | - | -0.43(-8.5%) |
Mar 2020 | - | -0.47(-23.0%) |
Dec 2019 | -0.61(-121.6%) | -0.61(-28.2%) |
Sept 2019 | - | -0.85(-34.1%) |
June 2019 | - | -1.29(+1.6%) |
Mar 2019 | - | -1.27(-145.0%) |
Dec 2018 | 2.82(-642.3%) | 2.82(-862.2%) |
Sept 2018 | - | -0.37(+15.6%) |
June 2018 | - | -0.32(-13.5%) |
Mar 2018 | - | -0.37(-28.8%) |
Dec 2017 | -0.52(-87.1%) | -0.52(-29.7%) |
Sept 2017 | - | -0.74(+5.7%) |
June 2017 | - | -0.70(-36.4%) |
Mar 2017 | - | -1.10(-72.8%) |
Date | Annual | Quarterly |
---|---|---|
Dec 2016 | -4.04(-741.3%) | -4.04(-162.0%) |
Sept 2016 | - | 6.52(+312.7%) |
June 2016 | - | 1.58(+75.6%) |
Mar 2016 | - | 0.90(+42.9%) |
Dec 2015 | 0.63(+18.9%) | 0.63(+21.2%) |
Sept 2015 | - | 0.52(-24.6%) |
June 2015 | - | 0.69(+13.1%) |
Mar 2015 | - | 0.61(+15.1%) |
Dec 2014 | 0.53(+165.0%) | 0.53(+26.2%) |
Sept 2014 | - | 0.42(-4.5%) |
June 2014 | - | 0.44(+100.0%) |
Mar 2014 | - | 0.22(+10.0%) |
Dec 2013 | 0.20(-57.4%) | 0.20(0.0%) |
Sept 2013 | - | 0.20(-90.2%) |
June 2013 | - | 2.05(+215.4%) |
Mar 2013 | - | 0.65(+38.3%) |
Dec 2012 | 0.47(-56.9%) | 0.47(-100.9%) |
Sept 2012 | - | -54.07(-2237.2%) |
June 2012 | - | 2.53(+45.4%) |
Mar 2012 | - | 1.74(+59.6%) |
Dec 2011 | 1.09(-705.6%) | 1.09(+186.8%) |
Sept 2011 | - | 0.38(+22.6%) |
June 2011 | - | 0.31(+158.3%) |
Mar 2011 | - | 0.12(-166.7%) |
Dec 2010 | -0.18(0.0%) | -0.18(-106.4%) |
Sept 2010 | - | 2.83(-1672.2%) |
Dec 2009 | -0.18(-51.4%) | -0.18 |
Dec 2008 | -0.37 | - |
FAQ
- What is the all time high annual debt to equity for AcelRx Pharmaceuticals?
- What is the all time high quarterly debt to equity for AcelRx Pharmaceuticals?
What is the all time high annual debt to equity for AcelRx Pharmaceuticals?
AcelRx Pharmaceuticals all-time high annual debt to equity ratio is 2.82
What is the all time high quarterly debt to equity for AcelRx Pharmaceuticals?
AcelRx Pharmaceuticals all-time high quarterly debt to equity ratio is 6.52